NA
ESPR icon

NewEdge Advisors’s Esperion Therapeutics ESPR Stock Holding History

NewEdge Advisors’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-600
Closed -$1.59K – 4267
2025
Q3 		$1.59K Hold
600
– – ﹤0.01% 3823
2025
Q2 		$591 Hold
600
– – ﹤0.01% 3781
2025
Q1 		$864 Hold
600
– – ﹤0.01% 3650
2024
Q4 		$1.32K Hold
600
– – ﹤0.01% 3522
2024
Q3 		$990 Sell
600
-100
-14% -$202 ﹤0.01% 3510
2024
Q2 		$1.55K Buy
700
+100
+17% +$235 ﹤0.01% 3381
2024
Q1 		$1.61K Hold
600
– – ﹤0.01% 3419
2023
Q4 		$1.79K Hold
600
– – ﹤0.01% 3357
2023
Q3 		$588 Hold
600
– – ﹤0.01% 3232
2023
Q2 		$834 Sell
600
-8,222
-93% -$11.5K ﹤0.01% 3274
2023
Q1 		$14K Buy
8,822
+8,222
+1,370% +$42.4K ﹤0.01% 2460
2022
Q4 		$4 Buy
+600
New +$4.29K ﹤0.01% 3837

Other funds holding ESPR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return